坎托菲茨杰拉德公司：维持Vera Therapeutics评级

证券之星2025-05-07

坎托菲茨杰拉德公司：维持Vera Therapeutics(VERA.US)评级，由增持调整至增持评级,目标价由107.00美元调整至100.00美元。Vera Therapeutics(VERA.US)公司简介：Vera Therapeutics Inc是一家临床阶段的生物技术公司。该公司专注于为患有严重免疫疾病的患者开发变革性疗法并将其商业化。该公司的候选产品是atacicept，是一种融合...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533930989?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-07 22:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2533930989","market":"us","top_or_hot":-1,"title":"坎托菲茨杰拉德公司：维持Vera Therapeutics评级","media":"证券之星","content":"<div>\n<p>坎托菲茨杰拉德公司：维持Vera Therapeutics(VERA.US)评级，由增持调整至增持评级,目标价由107.00美元调整至100.00美元。Vera Therapeutics(VERA.US)公司简介：Vera Therapeutics Inc是一家临床阶段的生物技术公司。该公司专注于为患有严重免疫疾病的患者开发变革性疗法并将其商业化。该公司的候选产品是atacicept，是一种融合...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>坎托菲茨杰拉德公司：维持Vera Therapeutics评级</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n坎托菲茨杰拉德公司：维持Vera Therapeutics评级\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-07 22:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>坎托菲茨杰拉德公司：维持Vera Therapeutics(VERA.US)评级，由增持调整至增持评级,目标价由107.00美元调整至100.00美元。Vera Therapeutics(VERA.US)公司简介：Vera Therapeutics Inc是一家临床阶段的生物技术公司。该公司专注于为患有严重免疫疾病的患者开发变革性疗法并将其商业化。该公司的候选产品是atacicept，是一种融合...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VERA","symbol_name":"Vera Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b","article_id":"2533930989","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2533930989","pubTimestamp":1746628875,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"坎托菲茨杰拉德公司：维持Vera Therapeutics(VERA.US)评级，由增持调整至增持评级,目标价由107.00美元调整至100.00美元。Vera Therapeutics(VERA.US)公司简介：Vera Therapeutics Inc是一家临床阶段的生物技术公司。该公司专注于为患有严重免疫疾病的患者开发变革性疗法并将其商业化。该公司的候选产品是atacicept，是一种融合蛋白，每周皮下注射一次，可阻断B淋巴细胞刺激剂和增殖诱导配体，它们会刺激B细胞和浆细胞产生导致某些自身免疫性疾病的自身抗体。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"VERA":"Vera Therapeutics, Inc.","LENZ":"Therapeutics"},"translate_title":"Cantor Fitzgerald: Maintain Vera Therapeutics Rating","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VERA":1,"LENZ":1},"content_text":"坎托菲茨杰拉德公司：维持Vera Therapeutics(VERA.US)评级，由增持调整至增持评级,目标价由107.00美元调整至100.00美元。Vera Therapeutics(VERA.US)公司简介：Vera Therapeutics Inc是一家临床阶段的生物技术公司。该公司专注于为患有严重免疫疾病的患者开发变革性疗法并将其商业化。该公司的候选产品是atacicept，是一种融合蛋白，每周皮下注射一次，可阻断B淋巴细胞刺激剂和增殖诱导配体，它们会刺激B细胞和浆细胞产生导致某些自身免疫性疾病的自身抗体。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533930989","isCrawlerRequest":true}